We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Genpact (NYSE: G) Acquires XponentL Data to Expand AI and Data Capabilities

Genpact (NYSE: G),a global provider of technology services and solutions, has announced the acquisition of XponentL Data, a company specializing in data products and artificial intelligence (AI) solutions. The acquisition is intended to enhance Genpact’s capabilities in data strategy, engineering, and AI implementation across …

Team Kalkine | 06 June 2025

Lincoln Financial Group (NYSE: LNC) and Bain Capital Complete GBP 825Mn Strategic Partnership and Investment

Lincoln Financial Group (NYSE: LNC)is a financial services company that provides a range of products including annuities, life insurance, group protection, and retirement plan services. As of late 2024, Lincoln Financial serves around 17 million customers and manages over GBP300 billion in account balances. …

Team Kalkine | 06 June 2025

Amazon (NASDAQ: AMZN) Launches AWS Asia Pacific (Taipei) Region to Expand Cloud Infrastructure in Taiwan

Amazon (NASDAQ: AMZN)operates a diverse range of businesses, including e-commerce, cloud computing, digital streaming, and artificial intelligence. The company focuses on long-term innovation and operational efficiency across its global operations.

Team Kalkine | 06 June 2025

ServiceTitan (Nasdaq: TTAN) Integrates with EagleView to Automate Roofing Measurement Data for Contractors

ServiceTitan (Nasdaq: TTAN), a software provider serving trades businesses, announced the launch of its integration with EagleView, a company specializing in aerial roofing measurements. This integration delivers EagleView’s property data directly into ServiceTitan’s platform, allowing contractors to access roof measurements within their existing workflow.

Team Kalkine | 06 June 2025

HSBC Upgrades Dr Reddy’s (NYSE:RDY) to Buy, Raises ADR Target to USD 16.90 on Semaglutide Outlook

HSBC has upgraded Dr Reddy’s Laboratories (NYSE:RDY) American Depositary Receipts (ADRs) fromHoldtoBuy, lifting its price target from USD 14.44 to USD 16.90. The move follows a revised outlook that anticipates a revenue boost from semaglutide, a generic alternative to Novo Nordisk’s high-demand weight-loss and …

Team Kalkine | 05 June 2025

JPMorgan Upgrades Dollar Tree (NASDAQ: DLTR) to Overweight, Hikes Price Target to USD 111

On Thursday, JPMorgan (NYSE:JPM) upgraded Dollar Tree (NASDAQ:DLTR) stock fromNeutraltoOverweight, revising its price target to USD 111 from USD 72. The upward adjustment reflects analyst optimism tied to key operational drivers and strategic cost initiatives.

Team Kalkine | 05 June 2025

Market Snapshot: Mixed Index Moves, Commodity Pressures, and Rising Layoff Concerns Amid Trade Uncertainty

Index Update:Shares of Five Below and MongoDB jumped in after-hours trading after both companies exceeded earnings and revenue expectations. Meanwhile, major indexes showed mixed performance, with the Dow slipping and the Nasdaq inching higher. Markets remained cautious as investors reacted to weak private-sector hiring …

Team Kalkine | 05 June 2025

Wallbox (NYSE: WBX) Secures $15Mn in Equity Investment Backed by Spanish Government and Existing Shareholders

Wallbox N.V. (NYSE: WBX), a global provider of electric vehicle (EV) charging and energy management solutions, has raised $15 million through two private placements of its Class A ordinary shares. The funding includes a public-sector investment of more than $9 million by the Government …

Team Kalkine | 05 June 2025

Yuanbao Inc. (NASDAQ: YB) Grows Revenue by 44% in Q1, Adds 6.8 Million New Insurance Policies

Yuanbao Inc. (NASDAQ: YB),a technology-led online insurance distributor in China, reported its unaudited financial results for the first quarter ended March 31, 2025, showing year-over-year growth across revenue, profitability, and policy volume.

Team Kalkine | 05 June 2025

Corcept Therapeutics (NASDAQ: CORT) DAZALS Trial Shows Survival Benefit in ALS Patients

Corcept Therapeutics Incorporated (NASDAQ: CORT)is a commercial-stage biopharmaceutical company headquartered in the United States. It focuses on discovering and developing therapies that modulate the effects of cortisol to treat a variety of serious disorders in endocrinology, oncology, metabolism, and neurology.

Team Kalkine | 05 June 2025
Support

Hi! How can we help you today?

Loading…